category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-2021,7.664161983259784e-6,0.9999998753439574,4,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-5788,7.664161983259784e-6,0.9999998753439574,4,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-6219,7.664161983259784e-6,0.9999998753439574,4,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-1782,6.273997112180515e-5,0.9999979877878086,4,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-5986,3.5330134973254065e-4,1,2,2,ammonium transport,BioCyc
ARA:PWY-101,4.415174989517097e-4,0.9999487679203591,6,46,photosynthesis light reactions,BioCyc
ARA:PWY-1001,5.582782468096019e-4,0.9999813252637094,3,20,cellulose biosynthesis,BioCyc
ARA:PHOTOALL-PWY,0.006410736462831641,0.9986858711624724,6,85,oxygenic photosynthesis,BioCyc
ARA:PWY-5343,0.011710856532228546,1,1,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-6787,0.01400801213877138,0.9984796995524614,3,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6406,0.016381172327506577,0.9999335543596021,1,2,salicylate biosynthesis I,BioCyc
ARA:PWY-7325,0.016981048265284137,1,1,1,salvigenin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,0.01747355674632246,0.9979113364116857,3,33,flavonoid biosynthesis,BioCyc
ARA:PWY-6232,0.020703274701086644,1,1,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-7186,0.02078260509775519,0.998689626677015,2,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-5049,0.021489361808044793,1,1,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-6064,0.035889467725377704,0.9996778129121469,1,2,methylquercetin biosynthesis,BioCyc
ARA:OXIDATIVEPENT-PWY,0.037661706763551295,0.996640906505776,2,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:PWY4FS-10,0.03967686129859038,0.9996054426196798,1,2,scopolin biosynthesis,BioCyc
ARA:PWY-6624,0.04216951682500234,0.999553726444613,1,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6762,0.04216951682500234,0.999553726444613,1,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-7468,0.04216951682500234,0.999553726444613,1,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,0.047404761461554215,0.9951708905438761,2,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:PWY-6303,0.07121090305517064,0.9979475916247486,1,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-5194,0.07862104183888233,0.9974902429710569,1,5,siroheme biosynthesis,BioCyc
ARA:PWY-2181,0.08637909549806878,0.9969603194488844,1,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:ETHYL-PWY,0.08941775798380897,0.986743760997634,2,31,ethylene biosynthesis I (plants),BioCyc
ARA:PWY-6364,0.10083103765001322,0.995243988187048,1,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6756,0.10882706011877075,0.9949310887696582,1,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PENTOSE-P-PWY,0.11076380838430872,0.9813010844468556,2,36,pentose phosphate pathway,BioCyc
ARA:PWY-5079,0.11348748501739456,0.9942102267068701,1,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-2724,0.11581494500047683,0.9936879760329477,1,12,alkane oxidation,BioCyc
ARA:PWY-6773,0.1169680840027006,0.993351487022824,1,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-1081,0.11707621044460147,0.9795438679885026,2,38,homogalacturonan degradation,BioCyc
ARA:PWY-5791,0.12709887627296942,0.9925856036140834,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5837,0.12709887627296942,0.9925856036140834,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-782,0.13297621971041365,0.9918642370769777,1,9,glycolipid desaturation,BioCyc
ARA:PWY-6444,0.14200493022058988,0.9902435960137785,1,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-2501,0.14208015611269542,0.9902329617551948,1,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-861,0.14350884449052628,0.9906245992579065,1,8,dhurrin biosynthesis,BioCyc
ARA:PWY-6754,0.15154284380169417,0.989351330284683,1,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-7270,0.1518475032450864,0.9689598004412832,2,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-6199,0.15256419643534416,0.9895699125306359,1,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-5391,0.1597202882069892,0.9881301136714606,1,9,syringetin biosynthesis,BioCyc
ARA:PWY-6546,0.1616175194591043,0.9878366523651368,1,9,brassinosteroids inactivation,BioCyc
ARA:PWY-5152,0.1675187039784115,0.9867445842181581,1,10,leucodelphinidin biosynthesis,BioCyc
ARA:ILE-VAL-PWY,0.18251780504078954,0.9833835476797446,1,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:PWY-3101,0.19449742884300034,0.9817534945788143,1,11,flavonol biosynthesis,BioCyc
ARA:PWY-6792,0.19647651998703677,0.9815385808366773,1,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6363,0.21099422587977326,0.9774733355803505,1,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY0A-6303,0.21104096050927124,0.9780550523255871,1,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-5486,0.21246242142651545,0.9774230491114646,1,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-6446,0.21862483415473755,0.9757371465424206,1,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-5321,0.21923494565506804,0.9436684612910531,2,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-6266,0.21923494565506804,0.9436684612910531,2,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,0.21923494565506804,0.9436684612910531,2,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:ILEUDEG-PWY,0.2509241288702241,0.9675959212480304,1,20,L-isoleucine degradation I,BioCyc
ARA:TRESYN-PWY,0.2518141410767445,0.9669076076277547,1,28,trehalose biosynthesis I,BioCyc
ARA:PWY-6443,0.25933257776055707,0.9253885653469166,2,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:DETOX1-PWY,0.27076201129275584,0.9618564451999622,1,21,superoxide radicals degradation,BioCyc
ARA:PWY-6823,0.2876655667248679,0.9567195561909076,1,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-7398,0.306433596301195,0.9505929930011708,1,19,coumarins biosynthesis (engineered),BioCyc
ARA:LEUSYN-PWY,0.31288542222679094,0.9475892187713284,1,27,L-leucine biosynthesis,BioCyc
ARA:PWY-6039,0.31940285179300176,0.9457514103626969,1,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY66-21,0.3216884436180851,0.9439914618913152,1,34,ethanol degradation II,BioCyc
ARA:VALDEG-PWY,0.3316546626409897,0.9404087854775678,1,30,L-valine degradation I,BioCyc
ARA:PWY-5936,0.34611582778623684,0.9349658150133078,1,26,xyloglucan biosynthesis,BioCyc
ARA:LEU-DEG2-PWY,0.3563886036304961,0.9302684590092126,1,32,L-leucine degradation I,BioCyc
ARA:PWY-5868,0.3710096198695539,0.9242075732125258,1,28,simple coumarins biosynthesis,BioCyc
ARA:DETOX1-PWY-1,0.37594355675631835,0.9219948275879343,1,28,reactive oxygen species degradation,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,0.37804183462490804,0.9204378998190555,1,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:PWYQT-62,0.3821273156884849,0.9187832754067365,1,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWY-3001,0.385462042094439,0.9168004818764987,1,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-7528,0.39842721886663685,0.9114268285986159,1,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWYQT-4475,0.4070394675468593,0.906885638997156,1,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWY-181,0.4215577980411527,0.8990170374109124,1,36,photorespiration,BioCyc
ARA:PWY-5992,0.5032435223844571,0.8493494331857181,1,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-1042,0.5372108810798447,0.8242840154340397,1,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1121,0.5531284692017983,0.8120647372035008,1,54,suberin monomers biosynthesis,BioCyc
ARA:GLYCOLYSIS,0.5558201853201585,0.8097941957158884,1,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:PWY-7219,0.5598332414401506,0.8075103478640291,1,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-361,0.5920830445590575,0.7796297451029581,1,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-5484,0.6113958926888291,0.7617407205288029,1,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PWYQT-4471,0.6520825715977774,0.7222721210302709,1,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:LIPAS-PWY,0.7480214054205804,0.606149941738823,1,93,triacylglycerol degradation,BioCyc
ARA:PWY-3781,0.8840144157607954,0.3732690468320407,1,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWYQT-4466,0.9999999999999967,0.5251162114668556,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWY-6466,0.9999999999999997,0.8716335697825353,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:ALACAT2-PWY,1,0.8503547484147358,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9070159154892204,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9070159154892204,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9339265818947754,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9642367908015242,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9623158020985559,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.9216120856794413,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.8199562403963625,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.782694353095232,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.7955487762999182,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9422299782181097,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.8927543976296463,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9422299782181097,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.8513287376298178,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.8513287376298178,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.7156834119846237,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.854146120905322,0,10,cyanide detoxification I,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.8068680934719051,0,12,spermidine biosynthesis I,BioCyc
ARA:CALVIN-PWY,1,0.5019274776203898,0,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:CAMALEXIN-SYN,1,0.5968037612375477,0,29,camalexin biosynthesis,BioCyc
ARA:CITRULBIO-PWY,1,0.656526125383096,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9820547882657645,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.8327441170779244,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.5532316520187529,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.9411483027870673,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.6600151117879358,0,25,L-cysteine biosynthesis I,BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.8390632970186831,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.7582173933437666,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.8680874695970225,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.4258363747086542,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.8212358889508375,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9824389085751741,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9709624041106496,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9376338485704102,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9376338485704102,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.7211820195475328,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9736149543517695,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.8368104139175281,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9256068567037586,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.77538227163821,0,17,glycine cleavage,BioCyc
ARA:GLYOXDEG-PWY,1,0.980489111027749,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.8001686815798522,0,17,glyoxylate cycle,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.8549778973154579,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.8712926918223094,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.7790731284474791,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.8256241675700531,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9685218123090216,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.7892854628272594,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9842005673823145,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9165842092558828,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.9172612110432842,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILEUSYN-PWY,1,0.8704259856895881,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9725802710612,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9806388433343901,0,1,L-cysteine degradation II,BioCyc
ARA:LIPASYN-PWY,1,0.349649168669314,0,72,phospholipases,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.873189862835022,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.756523410829447,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9372802128014643,0,4,D-mannose degradation,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,1,0.6756250724236306,0,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.8504977330073085,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.8238793850761085,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.8126150117330344,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.7683087791246799,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:P401-PWY,1,0.865673200598711,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9053957787740766,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9253134822972607,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PLPSAL-PWY,1,0.9439579866604528,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9582676188163185,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9551677283980745,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9539995762585933,0,4,L-proline degradation,BioCyc
ARA:PWY-102,1,0.8656566441622017,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1061,1,0.6502075466782121,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-112,1,0.9449121305658278,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-116,1,0.9356946385489056,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.9002184708953029,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.5570367765913554,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.8848838189851252,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.8656816287975639,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.8951586626174145,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.8748576626042142,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1801,1,0.9672212835119494,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-1822,1,0.8827123799437211,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9864407416425421,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9698437260183892,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2161,1,0.8314551796432564,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9121577129260237,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.8810953040714594,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2261,1,0.6171630615629402,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.9150537029744951,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2541,1,0.5292906418799643,0,44,plant sterol biosynthesis,BioCyc
ARA:PWY-2582,1,0.9126666999663472,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.9744204054215374,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.7594135133369585,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2781,1,0.9768689701001936,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.8718728065318908,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.7039438581308338,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.9204251471631364,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.8748074810801719,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.8748074810801719,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-2902,1,0.8727587022529556,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3041,1,0.9505684342414973,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3181,1,0.968291963960078,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.5979881520697782,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9801686262493596,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9425353556415483,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.5848623939522294,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9450147412841176,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.8340921431950689,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.8646434927100537,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.8107868698840975,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.7675612527091723,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.7857792763145569,0,26,choline biosynthesis III,BioCyc
ARA:PWY-3742,1,0.6320796466093199,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3801,1,0.6487207916512627,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.8389164500539364,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.8951545899318095,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.5837811679667022,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.8936312213422238,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.9198355587153731,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.9574230291230615,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9751823212128744,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9623158020985559,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.9027126249849372,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.8515280491007988,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.7706866397101877,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.7542134800386588,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9450601740045329,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.753722090624027,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9730075434945198,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.9183506590907548,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.17207771329393923,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4321,1,0.8643881295720984,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9882733074839638,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.72601098249807,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.8343324351967585,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.8486282121794374,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.790744211840439,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.8257364526713311,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9414769810511648,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.790744211840439,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.7668241266996219,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.8968709905355449,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.8921957019981085,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.9327904761169883,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.91851534038209,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.9207725343801757,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9925665275121688,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.950756550689298,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.77220242839598,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.9597240089559527,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.8134830318089862,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.7952206540369103,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.783354560081885,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5060,1,0.9311453851712158,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.9829608203506854,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9718898743150584,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9289897983886002,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.8333415030903021,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5080,1,0.5065089823646066,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5083,1,0.24022915458633845,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5084,1,0.8224428320079106,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.9887405279284579,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5097,1,0.7870768652638855,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5098,1,0.8832339095102696,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.9636108845240369,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9047102028873546,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9739722221518676,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.557320782769915,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9872676085724942,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.729888101043638,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.5522572877016512,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.7175357741526749,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5123,1,0.6756188361078073,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-5125,1,0.8609057831703693,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.6341969393456156,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.8360510808732003,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.8382030362402844,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.9076041941658533,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.8322289186492708,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.6813491056410074,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.849374485753005,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5168,1,0.9412917829333919,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.9117710420644911,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9875341842134164,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9903994151860066,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.8264932896429178,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5203,1,0.893496247805054,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5267,1,0.8615645156131134,0,9,glucosinolate activation,BioCyc
ARA:PWY-5269,1,0.8924198248366474,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5271,1,0.9705244149998071,0,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-5272,1,0.8289222842631,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.96392114814618,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9816277018387012,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9205411483108762,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.7380426527570868,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9673459240444104,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.8471342219941237,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,1,0.8295570709760979,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5342,1,0.9919302654628055,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5350,1,0.8155328106948974,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.9076041941658533,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.951346715040094,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.4844445600373772,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.7292423667529254,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9362374966281607,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5410,1,0.8762697598986064,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.9383614705041333,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.7571777827310027,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.9511300197424342,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9585870586940675,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9780838364775318,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5530,1,0.8918284622926905,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.5865818288415889,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9779412756922481,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.7889005439799426,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.8712747155449849,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5667,1,0.7048373476422823,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.9542046669866459,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5670,1,0.9246302790550055,0,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5686,1,0.9238072545506868,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.5725592781484864,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.5128086477673871,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9430222921226094,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9763813901065618,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9774680334099443,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9558837556516021,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.993278232023977,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.5295694648972816,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9402322797803893,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9685218123090216,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5800,1,0.8220875773965424,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9685218123090216,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5807,1,0.9050631821530261,0,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-581,1,0.6181614649190196,0,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-5859,1,0.7911923196677417,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5871,1,0.9105466959112782,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9697002867669985,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.6853388190906862,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.9450943659508592,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9413057794521122,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.8699861539477844,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.8362139503654856,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5943,1,0.9805850698633282,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9822258831896974,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9452536620302644,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9875341842134164,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9555238315897927,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9296511066661287,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.8664003093246126,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.528142290076695,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.6355469329608221,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5989,1,0.5413310103070392,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5995,1,0.9564787919155728,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9627389037972619,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.972752791033057,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.984740009156683,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.99324475384479,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9873025274029371,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.568307565942946,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9274998591497329,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9058432349124815,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9385471706696235,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6040,1,0.7985711405233956,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6051,1,0.866343906827427,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6066,1,0.9755668149274028,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9196915463703218,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.8959714636653001,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.8936479846510704,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.8936479846510704,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9333412704968735,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9868003762203224,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.9355681758756144,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.8882687598255039,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.8797739822233495,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.9282774332052658,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9610860955520395,0,2,D-serine metabolism,BioCyc
ARA:PWY-621,1,0.6737857137540191,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.9531556775072457,0,6,cadmium transport I,BioCyc
ARA:PWY-622,1,0.7558878208397578,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9404894655788332,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6233,1,0.9404894655788332,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9266193109250291,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9824183962683453,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6287,1,0.9384134379559023,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.955045098393741,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.8660442727177795,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6304,1,0.9372584419285654,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9448265710753089,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.863763506018445,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.8390632970186831,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6348,1,0.6016440261014535,0,27,phosphate acquisition,BioCyc
ARA:PWY-6351,1,0.5304974161856457,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.5457859116955882,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6367,1,0.8210525185242094,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9218612928441027,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-641,1,0.935307812876951,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9570416563985671,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.870354762012188,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.8971263831877053,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6457,1,0.8839604516345366,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6473,1,0.976451549377745,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.8600938450579444,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.9007014638742983,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.8710847098205746,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9722978725723234,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9473724693270976,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.8641301091598533,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.976451549377745,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.915764737346264,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.8838120669712397,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.6032043656869338,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6549,1,0.6560349208739139,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.790744211840439,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9377184011822579,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9602798746955975,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.7765432598491036,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9529193051508559,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.8723981850299525,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.834637626033501,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.8279406426151356,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.8482688366097672,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.813296533666976,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.8684416270995267,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.9065690883511066,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9782537571250977,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.9414845049165602,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6663,1,0.8052103070649616,0,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-6666,1,0.9618956498355793,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.8678288194775782,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9904929607427368,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9058432349124815,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.8301013685421821,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9201581744887666,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6733,1,0.5768230478619667,0,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6736,1,0.9532875832276515,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.8907001164704402,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6786,1,0.7395563183010635,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6799,1,0.976170176840731,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.972682864258579,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6803,1,0.37008877390082917,0,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-6804,1,0.9326573986220783,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9614743286091081,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6825,1,0.8477321461079785,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.8296852206768176,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6842,1,0.19970315764726781,0,71,glutathione-mediated detoxification II,BioCyc
ARA:PWY-6845,1,0.958133031508433,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6890,1,0.97543949563862,0,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-6898,1,0.8498360975158159,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.7118141133025904,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.8011016212749337,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9794218874044964,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9860379847153672,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9050190038250983,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.8019082612257145,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9193884610537925,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9937702517838685,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9678792365898792,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.8473862643687163,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9760272265157856,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.8136559304424184,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.797947827932294,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.7721417208987882,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.8528048540713143,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.8578821899795114,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.8177265927504432,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.8838120669712397,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9804850737631424,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.7881440912035775,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.6273596368361399,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.5448085962154773,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.8889352539002737,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.914796222517047,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.9132564256071789,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.9405315394530701,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9158551686062677,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9158551686062677,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9565746222210407,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.946551374904699,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.8995632100041014,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9576693211718693,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9633601653222946,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9648850634207258,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.640384419090293,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.8459246107010792,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.8969267878912036,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.5626123727079432,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.7433067031126317,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7187,1,0.6555394797317471,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.835099277426933,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.516473021395454,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.7339453059719595,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.8334013043385956,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.6110651422557629,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7204,1,0.7703703432301581,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.7367849729237542,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.8638127996702722,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.5738849608572556,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.40061872230460466,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.9080029212288862,0,7,wogonin metabolism,BioCyc
ARA:PWY-7221,1,0.715375929155439,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.7623104979475958,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.7953254777917907,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.7953254777917907,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.6844058510652361,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.5884247251925736,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9812268998394281,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9205411483108762,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7343,1,0.9047377632862356,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.9213516712525264,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.920754054169144,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.7030935443696148,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.773102778226507,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.6340806415509008,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7416,1,0.6386355556239158,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.8319646155398188,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.948349591485485,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.6228558247042058,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7560,1,0.801326849053094,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9571595779394552,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.8527701769114963,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9350451398991195,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-7640,1,0.9705244149998071,0,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-7985,1,0.9563132486023314,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9306102964049028,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9797990819371977,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9808457793591545,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.955045098393741,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.7953254777917907,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-882,1,0.7140206715082,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.78758787085754145,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9564110447637313,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9191588992436152,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9000464682923682,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.9150850382770512,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.8383678362640974,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9422299782181097,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.8671336887124783,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9610860955520395,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.5912230326284501,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-461,1,0.9076819846112156,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.8794308766872584,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.9699488688632802,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.8883826710904468,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY1F-353,1,0.9662478564098612,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9546451464851733,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9261765640635213,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9406965892709177,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.8614239061419107,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9339825190705205,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-11,1,0.957108928513031,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.9735806439932515,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.9735806439932515,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.8411872349232787,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.8853846497716136,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.8853846497716136,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.7624474200599003,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.8403249483235762,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.7744078926673033,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.6221073504417681,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-399,1,0.3887165011780614,0,62,gluconeogenesis III,BioCyc
ARA:PWY66-423,1,0.9121594902517886,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.8928466594587599,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.95292141736809,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.965325474974229,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9515964127979915,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9315518024925957,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9497235167476162,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.777426167200857,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.710416378549777,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.8840320634551019,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4470,1,0.9669336808647547,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4472,1,0.6471892444451746,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.6471892444451746,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.6471892444451746,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4476,1,0.8795401862591625,0,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWYQT-4477,1,0.7392351286621454,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.4953875757915002,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.8706777459266446,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-94,1,0.745803264893411,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.908549543759444,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.7319392170229787,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.8150307009698327,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.8800253697900933,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.9082216266212862,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.5496660817826532,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.8629087240232591,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.6339123681871232,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.7153037936125841,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRIGLSYN-PWY,1,0.39901755115107634,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:TRPSYN-PWY,1,0.7218622180337897,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.7902002176374425,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.8863950747315001,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALSYN-PWY,1,0.8364272153487642,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9578791497600632,0,4,xylose degradation I,BioCyc
ARA:PWY-5980,1.0000000000000004,0.5989290411643332,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY0-166,1.0000000000000004,0.6292802765929485,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
